Nursing Times’ new, open access, learning unit will teach nurses when and how to report suspected adverse drug reactions ...

The MHRA has released statistics on its pharmacovigilance inspections ... a serious violation of applicable legislation and guidelines. The most prevalent critical finding was reference safety ...

Pharmacovigilance is extremely important ... HB: Can you tell us a bit about the new MHRA guidelines, and how the expanded responsibilities of MHRA will benefit its stakeholders?

2025 Target Guidance 2025 Development Pipeline Anticipated ... and the Medicines and Healthcare Products Regulatory Agency (MHRA) BRIUMVI to treat adult patients with RMS who have active disease ...

“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...

The UK regulatory agency said that future updates may extend the guidance to other personalised therapies, including treatments for rare diseases. June Raine, MHRA’s CEO said: “As an enabling ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer ...